Contrasting Dopaminergic Patterns in two Forms of Genetic Hypertension

References

• Goldstein D. S. Plasma norepinephrine in essential hypertension. Hypertension 1981; 3: 48–52
   PubMed Web of Science ®Google Scholar
• Cuche J. L., Kuchel O., Barbeau A., Boucher R., Genest J. Relationship between the adrenergic nervous system and renin during adaptation to upright posture: A possible role for 3,4-dihydroxyphenethylamine (dopamine). Clin Sci 1972; 43: 481–489
   PubMed Web of Science ®Google Scholar
• Harvey J. N., Casson I. F., Clayden A. D., Cope G. F., Perkins C. M., Lee M. R. A paradoxical fall in urine dopamine output when patients with essential hypertension are given added dietary salt. Clin Sci 1984; 67: 83–88
   PubMed Web of Science ®Google Scholar
• Kuchel O., Buu N. T., Unger T., Lis M., Genest J. Free and conjugated plasma and urinary dopamine in human hypertension. J Clin Endocrinol Metab 1979; 48: 425–429
   PubMed Web of Science ®Google Scholar
• Kjeldsen S. E., Flaaten B., Eide I., Helgeland A., Leren P., Fonstelien E. Decreased peripheral dopaminergic activity in essential hypertension. Scand J Clin Lab Invest 1983; 43: 15–20
   PubMed Web of Science ®Google Scholar
• Kuchel O., Buu N. T., Larochelle P., Hamet P., Genest J. Episodic dopamine discharge in paroxysmal hypertension. Page's syndrome revisited. Arch Intern Med 1986; 146: 1315–1320
   PubMed Web of Science ®Google Scholar
• Wang P. C., Buu N. T., Kuchel O., Genest J. Conjugation patterns of endogenous plasma catecholamines in human and rat: A new specific method for analysis of glucuronide conjugated catecholamines. J Lab Clin Med 1983; 101: 141–151
   PubMed Web of Science ®Google Scholar
• Herlitz H., Lindin S., Fleming M., Currell M., Karlboy E., Berghund G. Hormonal patterns during development of hypertension in spontaneously hypertensive rats (SHR). Clin Exp Hypertension (A) 1982; 4: 915–935
   PubMed Web of Science ®Google Scholar
• Almgren O., Carlsson A., Snider S. Tissue dopamine levels as an indicator of tyrosine hydroxylase activity. Advances in the Biosciences: Peripheral Dopaminergic Receptors, J. L. Imbs, J. Schwartz. Pergamon Press, New York 1978; 20: 29–40
   Google Scholar
• Neff N. H., Karoum F., Hadjiconstantinou M. Dopamine containing small intensely fluorescent cells and sympathetic ganglion function. Fed Proc 1983; 42: 3009–3011
   PubMedGoogle Scholar
• Goldberg L. I. Dopamine receptors and hypertension: Physiologic and pharmacologic implications. Am J Med October, 1984; 5: 37–44
   Google Scholar
• Sowers J. R. Effects of bromocriptine on responses to stress in spontaneously hypertensive rats. Hypertension 1981; 3: 544–550
   PubMed Web of Science ®Google Scholar
• Racz K., Kuchel O., Buu N. T., Tenneson S. Peripheral dopamine synthesis and metabolism in spontaneously hypertensive rats. Circ Res 1986; 58: 889–897
   Google Scholar
• Racz K., Kuchel O., Buu N. T. Abnormal adrenal catecholamine synthesis in salt sensitive Dahl rats. Hypertension 1987; 9: 000–000
   Google Scholar
• Racz K., Kuchel O., Debinski W., Buu N. T. Improved high performance liquid chromatographic determination of dopamine-β-hydroxylase activity in tissues and plasma. J Chromatogr 1986, in press
   PubMedGoogle Scholar
• Debinski W., Kuchel O., Buu N. T., Racz K., Cantin M., Genest J. Atrial natriuretic factor is an inhibitory modulator of the rat ganglionic catecholamine synthesis in vitro. Proceedings of the Hypertension Satellite Symposium. July, 19–211986, B. C. Whistler, (Abstract)
   Google Scholar
• Ricksten S. E., Yao T., Ljung B., Thoren P. Distensibility of left atrium in normotensive spontaneously hypertensive rats. Scand J Physiol 1980; 110: 413–418
   PubMedGoogle Scholar
• Racz K., Kuchel O., Buu N. T., Gutkowska J., Debinski W., Cantin M., Genest J. Zona glomerulosa cell responses to atrial natriuretic factor in genetically hypertensive rats. Am J Physiol 1986; 251: H689–H692
   PubMed Web of Science ®Google Scholar
• Lackovic S., Neff M. H. Evidence that dopamine is a neurotransmitter in peripheral tissues. Life Sci 1983; 32: 1665–1674
   PubMed Web of Science ®Google Scholar
• Lokhandwala M. F., Barrett R. J. Review: Cardiovascular dopamine receptors: Physiological, pharmacological and therapeutic implications. J Auton Pharmac 1982; 3: 189–215
   Google Scholar
• Stier C. T., Jr, Brewer T. F., Dick L. B., Wynn N., Itskovitz H. D. Formation of biogenic amines by isolated kidneys of spontaneously hypertensive rats. Life Sci 1986; 38: 7–14
   PubMed Web of Science ®Google Scholar
• Winternitz S. R., Katholi R. E., Oparil S. Role of the renal sympathetic nerves in the development and maintenance of hypertension in the spontaneously hypertensive rats. J Clin Invest 1980; 66: 971–978
   PubMed Web of Science ®Google Scholar
• Campese V. M., Romoff M. S., Levitan D., Saglikes Y., Friedler R. M., Massry S. G. Abnormal relationship between sodium intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension. Kidney Internat 1982; 21: 371–378
   PubMed Web of Science ®Google Scholar
• Rapp J. P. Dahl salt-susceptible and salt-resistant rats. Hypertension 1982; 4: 753–763
   PubMed Web of Science ®Google Scholar
• Gill J. R., Jr, Gullner H. G., Lake C. R., Lakatua D. J. Abnormalities of adrenergic and dopaminergic nervous systems in salt-sensitive (SS) and salt-resistant (SR) essential hypertension (EH). Clin Res 1985; 33: 554A, (Abstract).
   Google Scholar
• Snider S., Kuchel O. Dopamine: An important neurohormone of the sympathoadrenal system. Significance of increased peripheral dopamine release for the human stress response and hypertension. Endocr Rev 1983; 4: 291–309
   PubMed Web of Science ®Google Scholar
• Williams G. H., Braley L. M., Menachery A. Decreased adrenal responsiveness to Angiotensin II: A defect present in spontaneously hypertensive rats. A possible model of essential hypertension. J Clin Invest 1982; 69: 31–37
   PubMed Web of Science ®Google Scholar
• Munoz-Ramirez H., Khosla M. C., Bumpus F. M., Khairallah P. A. Hypotensive effect of [sar1, thr8] Angiotensin II in spontaneously hypertensive sodium-depleted rats. Am J Physiol 1978; 234: H447–H453
   PubMed Web of Science ®Google Scholar
• Hope W., Majewski H., McCulloch M. W., Rand M. U., Story D. F. Evidence for a modulatory role of dopamine in sympathetic transmission. Circ Res 1980; 46(Suppl. 1)177–179, 1980
   Google Scholar
• Shoback D. M., Williams G. H., Moore T. J., Dluhy R. G., Podolsky S., Hollenberg N. K. Defect in the sodium modulated tissue responsiveness to Angiotensin II in essential hypertension. J Clin Invest 1983; 72: 2115–2124
   PubMed Web of Science ®Google Scholar
• Williams G. H., Hollenberg N. K. Converting enzyme inhibitors normalize the reduced adrenal responsiveness to angiotensin II in essential hypertension. J Hypertension 1984; 2(Suppl. 2)43–47
   PubMedGoogle Scholar
• Weinberger M. H., Luft F. C., Henry D. P. The role of the sympathetic nervous system in the modulation of sodium excretion. The Role of Salt in Cardiovascular Hypertension, M. J. Fregly, M. R. Kare. Academic Press, New York 1982; 281–291
   Google Scholar
• Witzgall H., Lorenz R., Von Werder K., Weber P. C. Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low renin hypertension and idiopathic hyperaldosteronism. Clin Sci 1985; 68: 291–299
   PubMed Web of Science ®Google Scholar
• Kikuchi K., Miyama A., Nakao T., Takigami Y., Kondo A., Mito T., Ura N., Tsuzuki M., Iimura O. Hemodynamic and natriuretic responses to intravenous infusion of dopamine in patients with essential hypertension. Jpn Circ J 1982; 46: 486–493
   PubMedGoogle Scholar
• Shikuma R., Kambara S., Yoshimura M., Takashina R., Yamasaki H., Takeda K., Takahashi H., Ijichi H. Dopaminergic modulation of salt-sensitivity in essential hypertension. Nippon Jinzo Gakkai Shi 1984; 26: 417–423
   PubMedGoogle Scholar
• Williams G. H., Hollenberg N. K. Non modulating essential hypertension: a subset particularly responsive to converting enzyme inhibitors. J Hypertension 1985; 3(Suppl. 2)581–587
   Google Scholar
• Cuche J. L., Kuchel O., Barbeau A., Genest J. Urinary homovanillic acid, dopamine and norepinephrine excretion in patients with essential hypertension. Can Med Assoc J 1975; 112: 443–446
   PubMed Web of Science ®Google Scholar
• Pinsker P., Bultasova H., Veselkova A., Rotnaglova Z. Pressor and depressor humoral systems in young men with borderline hypertension. Cor et vasa 1982; 141: 133–135
   Google Scholar
• Laragh J. H. Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. Am J Med 1973; 55: 262–274
   Google Scholar
• Folkow B., Di Bona G. F., Hjemdahl P., Toren P. H., Wallin B. G. Measurements of plasma norepinephrine concentrations in human primary hypertension. A word of caution on their applicability for assessing neurogenic contributions. Hypertension 1983; 5: 399–403
   PubMed Web of Science ®Google Scholar
• Cuche J. L., Kuchel O., Barbeau A., Langlois Y., Boucher R., Genest J. Autonomic nervous system and benign essential hypertension in man. Circ Res 1974; 35: 281–297
   Web of Science ®Google Scholar
• Racz K., Kuchel O., Gutkowska J., Buu N. T., Cantin M., Genest J. Dopaminergic control of atrial natriuretic factor release. Hypertension 1986; 8: 825, (Abstract)
   Web of Science ®Google Scholar